The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Epigenomics AG's share price is $2.50.
Epigenomics AG's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was $0.56. Hence, Epigenomics AG's PS Ratio for today is 4.46.
Good Sign:
Epigenomics AG stock PS Ratio (=2.82) is close to 1-year low of 2.79
The historical rank and industry rank for Epigenomics AG's PS Ratio or its related term are showing as below:
EPGNF'
s PS Ratio Range Over the Past 10 Years
Min: 0.89 Med: 28.3 Max: 162.65
Current: 2.82
During the past 13 years, Epigenomics AG's highest PS Ratio was 162.65. The lowest was 0.89. And the median was 28.30.
EPGNF's PS Ratio is ranked better than 53.15% of 222
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.98
vs EPGNF: 2.82
Epigenomics AG revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of Epigenomics AG was -92.40% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -50.00% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -34.20% per year.
During the past 10 years, the average Revenue per Share Growth Rate was -22.10% per year.
During the past 13 years, Epigenomics AG's highest 3-Year average Revenue per Share Growth Rate was 20.10% per year. The lowest was -50.00% per year. And the median was -10.30% per year.
Back to Basics: PS Ratio
Epigenomics AG PS Ratio Historical Data
The historical data trend for Epigenomics AG's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Epigenomics AG's PS Ratio
For the Diagnostics & Research subindustry, Epigenomics AG's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Epigenomics AG's PS Ratio Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Epigenomics AG's PS Ratio distribution charts can be found below:
* The bar in red indicates where Epigenomics AG's PS Ratio falls into.
Epigenomics AG PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Epigenomics AG's Share Price of today is $2.50. Epigenomics AG's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.56.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Epigenomics AG PS Ratio Related Terms
Thank you for viewing the detailed overview of Epigenomics AG's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Epigenomics AG (Epigenomics AG) Business Description
Epigenomics AG is a molecular diagnostics company, that focuses on developing and commercializing in vitro diagnostic liquid biopsy tests for the screening, early detection, and diagnosis of cancer. The company develops and markets procedures and devices for the production in quantity of particular epigenetic parameters such as DNA methylation patterns as well as the information technology bases necessary for their procurement and evaluation. It is engaged in the development of novel molecular diagnostic products for cancer. The company products include Epi proColon, Epi BiSKit, HCCBloodTest, and Epi proLung. The company operates in Europe, Asia, and North America, majority of its revenue derives from Asia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
EPGNF has been successfully added to your 